Recruiting NA Unmet Fertility Information Needs

Tests treatment safety and results for Unmet Fertility Information Needs

Official title Investigating the Efficacy of a Paediatric Fertility Preservation Decision Aid in Parents and Adolescents and Young Adults (CAYA) Cancer Survivors

ClinicalTrials.gov ID: NCT06894810

What this study is testing

What it's testing
The current standard of care for paediatric patients with cancer regarding preservation of their fertility (FP) is to provide high-quality information during the clinical consultation process. However, this approach depends on health provider knowledge and communication and has been shown to be sub-optimal in some situations.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 16 and older

You may be able to join if

  • for both parents and survivors:
  • Be able to communicate in English.
  • Signed written informed consent form. for parents only:
  • Parents/guardians of CAYA survivors who were ≤25 years (2) when diagnosed with cancer and have completed curative gonadotoxic treatment for survivors...
  • CAYA cancer survivors aged 16 years or over who have completed curative gonadotoxic treatment.

You likely can't join if

  • Exclusion Criteria for both parents and survivors:
  • CAYA patients currently undergoing cancer treatment and their parents/guardians.
  • CAYA patients who are palliative and their parents/guardians
  • A family member already in the study. Exclusion Criteria for survivors only:
  • Minors who are not deemed to be mature minors as per protocol
See the full eligibility criteria
Who can join
  • for both parents and survivors:
  • Be able to communicate in English.
  • Signed written informed consent form. for parents only:
  • Parents/guardians of CAYA survivors who were ≤25 years (2) when diagnosed with cancer and have completed curative gonadotoxic treatment for survivors only
  • CAYA cancer survivors aged 16 years or over who have completed curative gonadotoxic treatment.
  • Participants can be on long-term adjuvant or endocrine therapy.
  • Participants may have achieved a pregnancy or livebirth.
What rules you out
  • Exclusion Criteria for both parents and survivors:
  • CAYA patients currently undergoing cancer treatment and their parents/guardians.
  • CAYA patients who are palliative and their parents/guardians
  • A family member already in the study. Exclusion Criteria for survivors only:
  • Minors who are not deemed to be mature minors as per protocol

The study team makes the final eligibility decision.

Where it's taking place

  • Melbourne, Victoria, Australia

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 16 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Melbourne, Victoria, Australia. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.